Comparer des méthodes

	Dockage moléculaire	Modélisation de pharmacophores	QSAR
Domaine	Bio-informatique	Bio-informatique	Bio-informatique
Famille	Process / pipeline	Process / pipeline	Process / pipeline
Année d'origine	1982	1977	1964
Auteur d'origine	Irwin Kuntz	Peter Gund	Corwin Hansch
Type	Binding prediction pipeline	Pattern-based virtual screening pipeline	Regression-based predictive modeling pipeline
Source fondatrice	Kuntz, I. D., Blaney, J. M., Oatley, S. J., Langridge, R., & Ferrin, T. E. (1982). A geometric approach to macromolecule-ligand interactions. Journal of Molecular Biology, 161(2), 269-288.	Wermuth, C. G., Ganellin, C. R., Lindberg, P., & Mitscher, L. A. (1998). Glossary of terms used in medicinal chemistry. Pure and Applied Chemistry, 70(5), 1129-1143.	Hansch, C. & Fujita, T. (1964). Rho-sigma-pi analysis. A method for the correlation of biological activity and chemical structure. Journal of the American Chemical Society, 86(8), 1616-1626.
Alias	protein-ligand docking, binding prediction	pharmacophore pattern recognition, 3D pharmacophore	QSAR model, quantitative structure-activity relationship
Apparentées	4	3	3
Résumé	Molecular docking predicts the preferred binding orientation and affinity of a ligand (small molecule) within a protein binding pocket. Pioneered by Kuntz and colleagues in 1982, this computational method searches conformational space to find energetically favorable ligand-protein complexes, enabling rapid screening of chemical libraries for drug discovery.	Pharmacophore modeling identifies the spatial arrangement of molecular features (hydrogen bond donors, acceptors, aromatic rings) that are essential for biological activity. Introduced by Gund in 1977, this ligand-based method creates a three-dimensional pattern that can screen chemical libraries and design new active compounds without requiring receptor structure.	Quantitative Structure-Activity Relationship (QSAR) modeling predicts biological activity from molecular structure using statistical or machine learning models. Pioneered by Hansch in 1964, QSAR correlates numerical molecular descriptors with measured bioactivity, enabling prediction of activity for untested compounds and rational lead optimization.